DK1151007T3 - Fremgangsmåde til fremstilling af et præparat baseret på fibrinogen og fibronectin samt proteinsammensætninger fremstillet derved - Google Patents

Fremgangsmåde til fremstilling af et præparat baseret på fibrinogen og fibronectin samt proteinsammensætninger fremstillet derved

Info

Publication number
DK1151007T3
DK1151007T3 DK00906319T DK00906319T DK1151007T3 DK 1151007 T3 DK1151007 T3 DK 1151007T3 DK 00906319 T DK00906319 T DK 00906319T DK 00906319 T DK00906319 T DK 00906319T DK 1151007 T3 DK1151007 T3 DK 1151007T3
Authority
DK
Denmark
Prior art keywords
fibronectin
fibrinogen
preparation
protein compositions
well
Prior art date
Application number
DK00906319T
Other languages
English (en)
Inventor
Thomas Seelich
Ralf Broermann
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Application granted granted Critical
Publication of DK1151007T3 publication Critical patent/DK1151007T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK00906319T 1999-02-12 2000-02-10 Fremgangsmåde til fremstilling af et præparat baseret på fibrinogen og fibronectin samt proteinsammensætninger fremstillet derved DK1151007T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT20699 1999-02-12
US09/502,029 US6579537B2 (en) 1999-02-12 2000-02-10 Method for producing fibronectin and fibrinogen compositions using a polyalkylene glycol and glycine or β-alanine

Publications (1)

Publication Number Publication Date
DK1151007T3 true DK1151007T3 (da) 2006-09-04

Family

ID=25591856

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00906319T DK1151007T3 (da) 1999-02-12 2000-02-10 Fremgangsmåde til fremstilling af et præparat baseret på fibrinogen og fibronectin samt proteinsammensætninger fremstillet derved

Country Status (12)

Country Link
US (2) US6579537B2 (da)
EP (1) EP1151007B1 (da)
JP (1) JP2007131638A (da)
AT (1) ATE325133T1 (da)
AU (2) AU774118B2 (da)
CA (1) CA2362513C (da)
DE (1) DE60027695T2 (da)
DK (1) DK1151007T3 (da)
ES (1) ES2263451T3 (da)
PT (1) PT1151007E (da)
SI (1) SI1151007T1 (da)
WO (1) WO2000047621A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4771594B2 (ja) * 1999-02-12 2011-09-14 バクスター アクチェンゲゼルシャフト フィブリノーゲンおよびフィブロネクチンをベースとする製剤を生成するための方法ならびにこの方法により入手可能なタンパク質組成物
US8428685B2 (en) * 2001-09-05 2013-04-23 Given Imaging Ltd. System and method for magnetically maneuvering an in vivo device
US20050221035A1 (en) * 2004-04-01 2005-10-06 Derek Wyatt Method for reducing freeze-thaw voids in uncured adhesives
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
US20070231362A1 (en) * 2006-04-04 2007-10-04 3M Innovative Properties Company Schistose microfibrillated article for cell growth
US20070238167A1 (en) * 2006-04-04 2007-10-11 3M Innovative Properties Company Flat microfibers as matrices for cell growth
AU2008206052A1 (en) * 2007-01-18 2008-07-24 Baxter Healthcare S.A. Fibrin gel for controlled release of TGF-beta and uses thereof
MX2009013970A (es) 2007-06-19 2010-09-10 Baxter Int Gel de fibrina para la liberacion controlada del factor de crecimiento derivado de plaqueta (pdgf) y sus usos.
EP2034010A1 (en) 2007-08-30 2009-03-11 Omrix Biopharmaceuticals Ltd. Compositions suitable for repair and/or treatment of injured spinal tissue
US20100028311A1 (en) * 2008-07-09 2010-02-04 Baxter International Inc. Using of scaffold comprising fibrin for delivery of stem cells
PL2435102T3 (pl) 2009-05-28 2021-01-11 Addbio Ab Wielowarstwowe folie białkowe, sposoby ich wytwarzania, urządzenia do podawania leku oraz implanty biomedyczne wykorzystujące folie
WO2011085301A1 (en) 2010-01-08 2011-07-14 Baxter International Inc. Biomatrices to attract and retain regenerative and reparative cells
IL207586A0 (en) 2010-08-12 2010-12-30 Omrix Biopharmaceuticals Ltd A fibrin based therapeutic preparation and use thereof
EP2619225B1 (en) * 2010-09-20 2016-06-15 Octapharma AG Process for production of fibrinogen
KR101127127B1 (ko) * 2011-10-27 2012-03-21 주식회사 녹십자 고농도 피브리노겐 용액의 제조 방법 및 이를 이용한 피브린 실란트 제품의 제조방법
US8999376B2 (en) 2012-02-03 2015-04-07 Xcede Technologies, Inc. Tissue patch
US10112972B2 (en) 2012-03-13 2018-10-30 Octapharma Ag Process for production of fibrinogen and fibrinogen produced thereby
US11071805B2 (en) 2013-04-22 2021-07-27 Sealantium Medical Ltd. Fibrinogen-based tissue adhesive patches
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
US10588998B2 (en) 2015-08-07 2020-03-17 Xcede Technologies, Inc. Adhesive compositions and related methods
US11471556B2 (en) 2015-10-19 2022-10-18 Sealantium Medical Ltd. Fibrinogen-based tissue adhesive patch
CA3008674C (en) 2015-10-19 2024-02-13 Sealantium Medical Ltd Improved fibrinogen-based tissue adhesive patch
CN105617451A (zh) * 2016-02-29 2016-06-01 苏州市贝克生物科技有限公司 壳聚糖基止血材料及其制备方法
CN105770970A (zh) * 2016-02-29 2016-07-20 苏州市贝克生物科技有限公司 复合多糖止血薄膜及其制备方法
IL247821A0 (en) * 2016-09-14 2017-01-31 Omrix Biopharmaceuticals Ltd Adhesive preparations and their use
CN108017710B (zh) * 2018-01-19 2020-02-04 贵州泰邦生物制品有限公司 一种人纤维蛋白原的制备方法
CA3152224A1 (en) * 2019-08-22 2021-02-25 Abdalla S. AWIDI Method of preparing a de-fibrinated platelet lysate, and uses of said method
IL310285A (en) 2021-08-13 2024-03-01 Biotest Ag Fibrinogen preparations and preparation methods
WO2023119265A1 (en) 2021-12-21 2023-06-29 Omrix Biopharmaceuticals Ltd. Fibrinogen comprising formulation and uses thereof
ES2957484B2 (es) 2022-06-07 2026-04-06 Santxa Res S L U Gel de fibrina y método de obtención del mismo

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3105624A1 (de) * 1981-02-16 1982-09-02 Hormon-Chemie München GmbH, 8000 München Material zum abdichten und heilen von wunden
DE3203775A1 (de) 1982-02-04 1983-08-11 Behringwerke Ag, 3550 Marburg Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
AT389815B (de) 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
DK475386D0 (da) * 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen Fremgangsmaade og apparat til fremstilling af biologiske stoffer
JPH0199565A (ja) * 1987-10-12 1989-04-18 Green Cross Corp:The フィブリン糊調製用キット
AT397203B (de) 1988-05-31 1994-02-25 Immuno Ag Gewebeklebstoff
FR2639958B1 (fr) * 1988-12-06 1992-08-21 Lille Transfusion Sanguine Support biologique pour cultures cellulaires constitue de proteines plasmatiques coagulees par la thrombine, son utilisation pour la culture des keratinocytes, leur recuperation et leur transport a des fins d'utilisation therapeutique
US5196185A (en) * 1989-09-11 1993-03-23 Micro-Collagen Pharmaceutics, Ltd. Collagen-based wound dressing and method for applying same
AU1461592A (en) * 1991-02-07 1992-09-07 Fibratek, Inc. Fibrinogen based adhesive
JPH04347162A (ja) * 1991-05-23 1992-12-02 Japan Synthetic Rubber Co Ltd 生体組織接着剤
AT402891B (de) 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
US5288853A (en) * 1992-04-30 1994-02-22 Alpha Therapeutic Corporation Factor viii purification process
JP3133338B2 (ja) 1992-12-16 2001-02-05 イムノ・アクチエンゲゼルシャフト ウイルス的に安全な生物学的組成物の調製方法
US5395923A (en) 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
US5330974A (en) 1993-03-01 1994-07-19 Fibratek, Inc. Therapeutic fibrinogen compositions
AT402788B (de) 1993-08-03 1997-08-25 Immuno Ag Virussichere blutgerinnungsfaktor xiii-präparation
HRP940645A2 (en) 1993-10-06 1996-12-31 Immuno Ag Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained
AT406019B (de) 1995-05-08 2000-01-25 Immuno Ag Verfahren zur herstellung eines arzneimittels enthaltend ein oder mehrere plasmaderivate
DE19617369A1 (de) * 1996-04-30 1997-11-06 Immuno Ag Lagerstabile Fibrinogen-Präparate
AT407117B (de) 1997-09-19 2000-12-27 Immuno Ag Fibrinschwamm
US6056970A (en) * 1998-05-07 2000-05-02 Genzyme Corporation Compositions comprising hemostatic compounds and bioabsorbable polymers
JP4771594B2 (ja) * 1999-02-12 2011-09-14 バクスター アクチェンゲゼルシャフト フィブリノーゲンおよびフィブロネクチンをベースとする製剤を生成するための方法ならびにこの方法により入手可能なタンパク質組成物

Also Published As

Publication number Publication date
ATE325133T1 (de) 2006-06-15
US7241603B2 (en) 2007-07-10
CA2362513A1 (en) 2000-08-17
DE60027695D1 (de) 2006-06-08
AU2004201982A1 (en) 2004-06-03
US20020172718A1 (en) 2002-11-21
EP1151007B1 (en) 2006-05-03
US20030077270A1 (en) 2003-04-24
JP2007131638A (ja) 2007-05-31
CA2362513C (en) 2011-04-26
EP1151007A1 (en) 2001-11-07
DE60027695T2 (de) 2007-04-26
SI1151007T1 (sl) 2006-10-31
AU2004201982B2 (en) 2007-12-06
ES2263451T3 (es) 2006-12-16
US6579537B2 (en) 2003-06-17
PT1151007E (pt) 2006-07-31
WO2000047621A1 (en) 2000-08-17
AU2804100A (en) 2000-08-29
AU774118B2 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
SI1151007T1 (sl) Postopek za pripravo pripravka na osnovi fibrinogena in fibronektina in proteinski sestavki, ki jihlahko dobimo po tem postopku
DE60228961D1 (de) Verfahren zur herstellung von l-aminosäuren durch enterobacteriaceae-stämmen mit verstärkter expression des mop-b
ATE489365T1 (de) Verfahren und zwischenprodukte zur herstellung von (1r,2s,5s)-6,6-dimethyl-3-azabicycloä3,1,0 ühexan-2-carboxylaten oder salzen davon
NO20073846L (no) Ladet termoplastisk resin-basert bitumlinos mastik
ATE501113T1 (de) Verfahren zur herstellung von 2-halogenacyl-3- amino-acrylsäure- derivaten
ATE426021T1 (de) Verfahren zur herstellung von biopterinen
DE60119711D1 (de) Verfahren zur herstellung von funktionalierten polyalkyleniminen, diese enthaltende zusammenstellungen und ihre verwendungen
DE60042035D1 (de) Verfahren und zusammensetzungen zur herstellung von ophtalmischen linsen
ATE293632T1 (de) Verfahren zur herstellung von alkylverbrückten ligandsystemen und übergangsmetallverbindungen
ATE256695T1 (de) Verfahren zur herstellung von pharmazeutisch annehmbaren salzen des (ss,rs)-s-adenosyl-l- menthionin
DE60003282D1 (de) Verfahren zur reinigung von hyaluronsäure mit hohem molekulargewicht
BRPI0416672A (pt) método de produção de uma composição granular contendo lecitina e composição granular contendo lecitina
ATE335750T1 (de) Verfahren zur herstellung von organosilylalkylpolysulfanen
ATE359287T1 (de) Ein verfahren zur herstellung von clopidogrel
ATE389010T1 (de) Verfahren zur herstellung von optisch aktiven pyridinethanol-derivaten
ATE440605T1 (de) Verfahren zur herstellung von camptothecin- derivaten
DE60336328D1 (de) Verfahren zur produktion von pflanzen mit verbesserter transpirationseffizienz sowie davon produzierte pflanzen
TW200502252A (en) Formulations of modified antibodies and methods of making the same
DE59709792D1 (de) Ringannelierte dihydropyrane, verfahren zur herstellung sowie deren verwendung
ATE272038T1 (de) Verfahren zur herstellung von 2-alkyl-3- chlorphenolen
ATE297665T1 (de) Verfahren zur herstellung von tomatenflocken
ATE271053T1 (de) Verfahren zur herstellung von beta-hydroxyestern
ATE375355T1 (de) Verfahren zur herstellung von cefpodoxim-proxetil
DE59904461D1 (de) Verfahren zur stereoselektiven herstellung von substituierten cyclohexylcyanhydrinen
ATE387432T1 (de) Verfahren zur herstellung von dtpa-bis-anhydrid